Vitamin Blue Current Valuation vs. Total Asset

VTMB Stock  USD 0.0001  0.00  0.00%   
Based on the measurements of profitability obtained from Vitamin Blue's financial statements, Vitamin Blue may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in April. Profitability indicators assess Vitamin Blue's ability to earn profits and add value for shareholders.
For Vitamin Blue profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Vitamin Blue to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Vitamin Blue utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Vitamin Blue's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Vitamin Blue over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
Please note, there is a significant difference between Vitamin Blue's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vitamin Blue is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vitamin Blue's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Vitamin Blue Total Asset vs. Current Valuation Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Vitamin Blue's current stock value. Our valuation model uses many indicators to compare Vitamin Blue value to that of its competitors to determine the firm's financial worth.
Vitamin Blue is rated first in current valuation category among related companies. It is rated first in total asset category among related companies fabricating about  0.04  of Total Asset per Current Valuation. The ratio of Current Valuation to Total Asset for Vitamin Blue is roughly  24.18 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Vitamin Blue by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vitamin Blue's Pink Sheet . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vitamin Blue's earnings, one of the primary drivers of an investment's value.

Vitamin Current Valuation vs. Competition

Vitamin Blue is rated first in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Leisure industry is at this time estimated at about 136.7 Billion. Vitamin Blue adds roughly 766,886 in current valuation claiming only tiny portion of all equities under Leisure industry.

Vitamin Total Asset vs. Current Valuation

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Vitamin Blue

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
766.89 K
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Vitamin Blue

Total Asset

 = 

Tangible Assets

+

Intangible Assets

 = 
31.72 K
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.

Vitamin Total Asset Comparison

Vitamin Blue is currently under evaluation in total asset category among related companies.

Vitamin Blue Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Vitamin Blue, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Vitamin Blue will eventually generate negative long term returns. The profitability progress is the general direction of Vitamin Blue's change in net profit over the period of time. It can combine multiple indicators of Vitamin Blue, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Vitamin Blue, Inc. designs, develops, produces, and distributes water boardsports apparel and related products primarily in the United States. Vitamin Blue, Inc. was founded in 1999 and is based in Costa Mesa, California. Vitamin Blue operates under Leisure classification in the United States and is traded on OTC Exchange. It employs 1 people.

Vitamin Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Vitamin Blue. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Vitamin Blue position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Vitamin Blue's important profitability drivers and their relationship over time.

Use Vitamin Blue in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vitamin Blue position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vitamin Blue will appreciate offsetting losses from the drop in the long position's value.

Vitamin Blue Pair Trading

Vitamin Blue Pair Trading Analysis

The ability to find closely correlated positions to Vitamin Blue could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vitamin Blue when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vitamin Blue - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vitamin Blue to buy it.
The correlation of Vitamin Blue is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vitamin Blue moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vitamin Blue moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vitamin Blue can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Vitamin Blue position

In addition to having Vitamin Blue in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Buywrite ETFs Thematic Idea Now

Buywrite ETFs
Buywrite ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Buywrite ETFs theme has 23 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Buywrite ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Vitamin Pink Sheet analysis

When running Vitamin Blue's price analysis, check to measure Vitamin Blue's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitamin Blue is operating at the current time. Most of Vitamin Blue's value examination focuses on studying past and present price action to predict the probability of Vitamin Blue's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitamin Blue's price. Additionally, you may evaluate how the addition of Vitamin Blue to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Money Managers
Screen money managers from public funds and ETFs managed around the world
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
To fully project Vitamin Blue's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Vitamin Blue at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Vitamin Blue's income statement, its balance sheet, and the statement of cash flows.
Potential Vitamin Blue investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Vitamin Blue investors may work on each financial statement separately, they are all related. The changes in Vitamin Blue's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Vitamin Blue's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.